▎ VIAL TRUST REPORTLast evaluated July 8, 2026
BioLongevity Labs
VIAL · BIOLONGEVITY LABS · GREY MARKET VENDOR
TYPEHQSTATESGrey Market VendorOH50
Vial Score
getvial.com/report/biolongevity-labs40/100
Confirmed adverse record on fileVial Score over time
46 (May 30) → 40 (Jul 8) · 6 snapshots
Scoring method updated: a Vial change, not a provider change.
6 of 6 applicable signals confirmed
We confirmed all 6 checks that apply to this vendor type.
WHAT WE CONFIRMED
- Physician network disclosed
- Individual prescribers named
WHAT WE COULDN'T VERIFY
- NPI not confirmed in federal registry
- LegitScript certification not confirmed
Where this score differs
How BioLongevity Labs compares with similar providers Vial tracks.
- Compare →BioLongevity Labs vs Simple PeptideBioLongevity Labs scores 40 — compare with Simple Peptide side-by-side
- Compare →BioLongevity Labs vs Limitless Life NootropicsBioLongevity Labs scores 40 — compare with Limitless Life Nootropics side-by-side
- Compare →BioLongevity Labs vs Core PeptidesBioLongevity Labs scores 40 — compare with Core Peptides side-by-side
Before you pay, ask
Questions to bring to BioLongevity Labs before committing.
- 01Who is medically responsible for prescribing decisions, and what are their credentials?
- 02What is the all-in cost of the protocol you're recommending?
- 03What documentation can you provide to back the compliance claims on your website?
- 04What happens to my care and prescriptions if I want to discontinue?
Share
WHAT THIS MEANS
This provider's federal NPI registration could not be confirmed. Ask for the prescribing physician's NPI directly.
No FDA enforcement actions are on record for this provider in the public openFDA database.
Some legitimate providers — particularly newer brands and small practices — have minimal public records. This isn't proof of risk, but it does mean trust has to be established directly with the provider rather than via federal databases.
REPORT HISTORY▸ Latest: Jun 5 2026 · Score decreased 31 pts → 40/100
May 30, 2026
Vial score established · 46/100
May 31, 2026
Score increased 12 pts → 58/100
Jun 01, 2026 · SCORING ENHANCEMENT
Vial scoring enhancement
Scores were recalculated under an evidence-weighted model: a provider's score now reflects how much Vial has verified, so thinly-documented records sit near the neutral baseline instead of reaching the extremes. Lab credentials (CLIA/CAP) were added as positive evidence, a verified-clean US federal record (FDA/OIG/DEA) now counts toward regulatory standing for US-based providers (a clean US screen is not credited to an overseas provider that those registries would never list), every scored dimension holds a consistent neutral baseline where Vial has not yet verified it, and grey-market vendors are flagged. This is a Vial scoring change, not a change at the provider.
Jun 05, 2026
Score decreased 31 pts → 40/100
WHEN WE LAST CHECKED
FDA2026-06-03
OIG2026-07-06
DEA2026-07-27
HIPAA2026-07-06
NPI2026-07-06
PCAB2026-06-04
Are you BioLongevity Labs?
Claim this profile to add disclosures, or dispute findings with documentation.
Want us to watch BioLongevity Labs for you?
We'll email you if anything changes about this provider:
- A new enforcement action appears
- Their Vial Score moves
- Their pharmacy partner changes
- Complaint patterns emerge
Free. We’ll only email when something actually changes.